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Leukopenia, hypoxia, and complement function with different
hemodialysis membranes. Complement activation during ex-
posure of plasma to cuprophan has been postulated to cause Ieu-
kopenia and hypoxia in hemodialysis patients. To determine if
hypoxia is related to leukopenia and if complement activation
leads to a depletion of functional complement components, we
dialyzed four patients three times sequentially against each of
four types of membranes: cuprophan, regenerated cellulose, cel-
lulose acetate, and polyacrilonitrile. Within 20 mm there was a
marked leukopenia with cuprophan from 5541 376 to 1216 94
(P < 0.001) and with regenerated cellulose from 5541 411 to
1533 203 (P <0.001). With cellulose acetate, the change from
5558 400 to 3783 341 (P < 0.001) was less dramatic, and with
polyacrilonitrile the fall from 5591 381 to 4641 401 (P <0.02)
was minimal. After 2 and 4 hours of dialysis, a rebound leukocy-
tosis was seen with cuprophan, regenerated cellulose, and cellu-
lose acetate, but not with polyacrilonitrile. Transient thrombo-
cytopenia occurred with cuprophan and regenerated cellulose. In
spite of the variable degree of leukopenia, all membranes in-
duced a similar and significant hypoxia, which was progressive
throughout dialysis, even during the rebound leukocytosis. After
4 hours, the mean P02 ranged from 91 to 93 mm Hg with all mem-
branes. Functional hemolytic titers of whole complement, C3,
CS, and C4 were normal prior to hemodialysis and failed to de-
crease after 4 hours with any membrane. It is concluded that
hemodialysis leukopenia is membrane-dependent and is not the
cause of hypoxia. In addition, hemodialysis complement activa-
tion does not lead to functional complement depletion and is of
no clinical significance.
Leucopénie, hypoxie, et fonction du complement avec dif-
férentes membranes d'hémodialyse. L'activation du complement
au cours de l'exposition du plasma au cuprophane a été rendue
responsable de Ia leucopénie et de l'hypoxie chez les malades
hemodialysés. Afin de verifier que l'hypoxie est liée a Ia leuco-
pénie et que l'activation du complement determine une déplé-
tion des composants du complement nous avons dialyse quatre
malades trois fois consécutives avec chacun des quatre types
suivants de membranes: cuprophane, cellulose régénérée, ace-
tate de cellulose et polyacrilonitrile. Aprés 20 mm il y a une leu-
copénie importante avec le cuprophane, de 5541 376 a 1216
94 (P < 0,001), et avec Ia cellulose rCgCnérée, de 5541 411 a
1533 203 (P < 0,001). Avec l'acétate de cellulose la chute de
5558 400 a 3783 341 (P <0,001) est moms importante et avec
le polyacrilonitrile Ia diminution de 5591 381 a 4641 401 (P <
0,02) est minime. Après 2 et 4 heures de dialyse, un rebond de
leucocytose a été observe avec le cuprophane, Ia cellulose rég-
énérCe et l'acétate de cellulose mais pas avec le polyacrilonitrile.
Une thrombocytopénie transitoire est survenue avec le cupro-
phane et Ia cellulose régénérée. En dépit du degré variable de
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leucopCnie toutes les membranes déterminent une hypoxie sem-
blable qui est progressive au fur et a mesure de Ia dialyse, mCme
pendant le rebond de leucocytose. Après 4 heures Ia P02
moyenne est de 91 a 93 mm Hg avec toutes les membranes. Les
titres du complement hémolytique total, C3, CS, et C4 Ctaient
normaux avant l'hémodialyse et n'ont diminué, après 4 heures,
avec aucune membrane. II est conclu que La leucopénie de
l'hémodialyse depend de la membrane et n'est pas Ia cause de
l'hypoxie. Dc plus, l'activation du complement au cours de
l'hémodialyse n'entraine pas de depICtion du complement et n'a
pas de traduction clinique.
Hypoxia, leukopenia, and complement activation
may occur in uremic patients undergoing chronic
maintenance hemodialysis [1]. The initiating mech-
anism of these phenomena is felt to be activation of
plasma complement proteins through contact with
the dialysis membrane. This leads to formation of
leukocytes microaggregates that are subsequently
entrapped in the pulmonary circulation, thereby
causing leukopenia and possibly leading to hypoxia
[2]. The resultant early hypoxia is dependent on cir-
culating leukocytes. Two observations, however,
suggest that additional mechanisms may be in-
volved in causing hypoxia. First, although leuko-
penia is reversible within 1 hour, the hypoxia con-
tinues throughout the duration of hemodialysis [3].
Second, hypoxia has been noted to occur with
dialyzers that do not cause leukopenia [4]. More-
over, if complement is continuously activated
throughout dialysis, the leukopenia should persist
for a greater period of time. Additionally, com-
plement activation for the duration of each dialysis
may potentially lead to depletion of functional corn-
Received for publication January 8, 1980
and in revised form March 25, 1980
0085—2538/8010018-0505 $01.00
© 1980 by the International Society of Nephrology
506 Jacob et a!
plement components and underlie the propensity of
hemodialysis patients to bacterial infection. To in-
vestigate these possibilities, we prospectively stud-
ied the effect of repeated dialysis with cuprophan,
regenerated cellulose, cellulose acetate, and poly-
acrilonitrile membranes on white blood cell and
platelet counts, arterial blood gases, and com-
plement titers.
Methods
We studied four patients, aged 30 to 45 years, se-
quentially dialyzed with a different artificial kidney
membrane each week for 4 weeks. All four patients
were dialyzed for at least 4 hours thrice weekly with
an acetate bath (41 mEq/liter). Thus, each dialyzer
was studied for 12 dialysis sessions. The sequence
of membranes used was regenerated cellulose (C-
DAK 1.3, Cordis-Dow, Inc., Miami, Florida), cellu-
lose acetate (C-DAK 3500), cuprophan (Travenol
1500, Travenol Labs, Inc., Morton Grove, Illinois),
and polyacrilonitrile (RP-6, Hospal, Inc., Denver,
Colorado). No patient had a renal disease associat-
ed with complement abnormalities. Circulatory ac-
cess was obtained through an arteriovenous fistula,
and heparin was used to maintain anticoagulation.
Predialysis blood was drawn anaerobically into a
disposable syringe containing 100 U of sodium
heparin immediately after insertion of the needle in-
to the fistula and prior to exposure of blood to the
membrane. Blood samples were also drawn at 20,
120, and 240 mm after initiating hemodialysis from
the arterial line. An aliquot of blood for white cell
and platelet counts was transferred into tubes con-
taining EDTA, and another aliquot was removed,
the plasma separated, and immediately frozen at
—70° C for later determination of complement ti-
ters.
Serum complement assays for whole complement
and individual complement components were per-
formed with a hemolytic microtiter plate assay [5].
Dilutions of plasma were made in glucose-gelatin
verona! buffer by using microtiter dilutions and V-
bottom microtiter plates. Reagents supplying all
components of complement, Cl to C9, except the
component being tested for, are then added. Certain
components are supplied in the form of stable cellu-
lar intermediates consisting of antibody-sensitized
red blood cells (EA) with complement components
and included EAC1, EAC4, EAC14, EACI-7. Oth-
er components are added in the form of purified
components such as C2, C3, CS, C6, C7, C8, C9, or
modified complement serum capable of supplying
the late components of complement. The degree of
lysis is determined in each reaction mixture, and re-
sults are expressed as the reciprocal of the highest
dilution of serum that will hemolyze 50% of the red
cells in the reaction mixture (CH50 units/ml).
Arterial blood gases were measured inmediately
with a Radiometer BMS3 (Copenhagen, Denmark),
and white blood cell and platelet counts were ob-
tained within 4 hours on a Coulter Model S (Coulter
Corp., Miami, Florida). Data are expressed as the
means SEM. Statistical analysis was performed by
analysis of variance and Duncan's New Multiple
Range Test. A P value less than 0.05 was consid-
ered significant.
Results
The leukocyte count in all patients prior to hemo-
dialysis was similar with all four membranes. With-
in 20 mm after the initiation of hemodialysis, there
was a marked drop in leukocyte count from 5541
376 to 1216 94 cells/mm3 (P <0.001) with the re-
generated cellulose dialyzer and a similar drop from
5541 411 to 1533 203 mm3 (P <0.001) with the
cuprophan dialyzer. The decrease in leukocyte
count with the cellulose acetate dialyzer from 5558
400 to 3783 341 mm3 (P <0.05) was less dra-
matic. The polyacrilonitrile dialyzer caused a slight
but significant drop from 5591 381 to 4641 401
mm3 (P < 0.02) (Fig. 1). A rebound leukocytosis
was noted with all but the polyacrilonitrile mem-
branes at 120 and 240 mm (P < 0.001). A slight drop
in platelet count at 20 mm from 242,250 9955 to
216,000 7115 mm3 (P < 0.001) was observed
with the regenerated cellulose dialyzer. A similar
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Fig. 1. Change in leukocyte count during 240 mm of hemodialysis
with four membranes: cuprophan (CU), regenerated cellulose
(RC), cellulose acetate (CA), polyacrilonitrile (PAN).
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normal prior to dialysis and tended to increase dur-
ing hemodialysis (Table 3). Although the increases
were statistically significant for some complement
components and some kidneys, the trend occurred
with all four components and all four kidneys. More
importantly, there was no drop in titer of any com-
plement component with any kidney either before
or during hemodialysis.
Discussion
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Fig. 2. Change in Pa2 during 240 mm of hemodialysis with four
membranes: cuprophan (CU), regenerated cellulose (RC), cell,,-
lose acetate (CA), polyacrilonitrile (PAN).
drop from 244,166 12,584 to 224,166 10,372
mm3 (P < 0.02) was noted with the cuprophan
dialyzer. Po2 decreased progressively with all mem-
branes throughout hemodialysis (Fig. 2). With the
regenerated cellulose dialyzer, the Po2 fell from 107
3 mm Hg to 104 3 mm Hg at 20 mm and contin-
ued to fall to 93 2 mm Hg (P <0.001) at 120 mm
and 91 2 mm Hg (P <0.001) at 240 mm. A similar
decrease was noted with cuprophan, cellulose ace-
tate, and polyacrilonitrile membranes. The dif-
ferences between the kidneys in the degree of hy-
poxia were not significant; that is, all kidneys caused
the same degree of hypoxia.
As expected, metabolic acidosis resolved after 4
hours of hemodialysis (Table 1). Prior to hemo-
dialysis, the mean arterial pH for all groups ranged
from 7.300 to 7.332. After 240 mm, the pH had in-
creased into the range of 7.391 to 7.420. The in-
crease in arterial pH was similar with all mem-
branes and highly significant (P <0.001). The arte-
rial Pco2 was decreased prior to hemodialysis and
did not change (Table 2) after 4 hours of hemo-
dialysis with any membrane. Mean reciprocal titers
Over a decade ago, acute leukopenia was de-
scribed in patients undergoing hemodialysis [6].
The leukopenia was thought to be limited to gran-
ulocytes and monocytes and reversible within 1
hour. Experiments in hemodialyzed dogs and using
simultaneous sampling across the pulmonary vascu-
lar bed have shown that the leukopenia is due to
pulmonary sequestration of leukocytes [7]. After 2
to 3 hours of hemodialysis, a rebound of the neutro-
phil count to greater than predialysis levels has
been observed and results from a bone marrow re-
sponse [8]. In a detailed investigation of the patho-
genesis of this abnormality, Craddock et at [2]
showed that dialyzer cuprophan activates com-
plement through the alternate pathway both in vitro
and in hemodialysis patients. Moreover, com-
plement components generated by exposure of
plasma to cuprophan lead to a sequestration of leu-
kocytes within the lung when injected i.v. into rab-
bits. Thus, it has been proposed that exposure of
plasma to the cellophan dialysis membrane acti-
vates complement leading to intravascular aggre-
gates of leukocytes that are entrapped in the lung.
The transience of the leukopenia results from
coating of the membrane with plasma compon-
ents, with a subsequent inability to further acti-
vate complement proteins. Thus, the relationship
between exposure of plasma to the cuprophan
membrane and leukopenia is well established. Ob-
servations in uremic patients have shown that soon
after initiating hemodialysis there is a decrease in
arterial oxygen tension and pulmonary diffusing ca-
pacity as well as an increase in closing volume [1, 3].
Table 1. Change in arterial pH during hemodialysis with different membranesa
o mm 20 mm 120mm5 240 mm"
Regenerated cellulose 7.308 0.015 7.314 0.009 7.382 0.012 7.420 0.010
Cuprophan 7.310 0.009 7.310 0.008 7.372 0.012 7.420 0.013
Cellulose acetate 7.332 0.007 7.319 0.005 7.384 0.009 7.407 0.008
Polyacrilonitrile 7.300 0.015 7.311 0.013 7.352 0.014 7.391 0.011
a Values are the means SEM.
P < 0.001 for all membranes.
80 * P<0.05
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Table 2. Change in arterial Pco2 (mm Hg) during hemodialysis with different membranesa
0mm 20mm 120mm 240mm
Regeneratedcellulose 35.3 1.1 35.8 1.5 34.3 1.2
Cuprophan 32.2 1.2 32.6 1.2 32.1 1.2
Cellulose acetate 33.3 0.8 34.6 1.0 32.9 1.2
Polyacrilonitrile 32.6 1.1 32.4 1.2 31.7 0.9
34.7 1.1
31.4 1.3
32.6 1.0
30.1 1.2
a Values are the means SEM.
Table 3. Change in hemolytic complement titers during hemodialysis with different membranesa
WhC C4' C3c CS"
0 mm 240 mm 0 mm 240 mm 0 mm 240 0 mm 240 mm
Regenerated cellulose 84 5 96 7 77 6 98 7" 140 9 142 13 27 1
Cuprophan 89 6 91 5 79 6 87 7" 128 137 6 26 1
Cellulose acetate 83 6 105 7" 72 6 77 6 117 10 163 10 29 1
Polyacrilonitrile 89 4 99 3<' 88 8 105 6 115 10 169 10 28 2
34 3"
28 230 2
30 1
a Values are the means SEM.
b x 10
c x 102
u p < 0.05
Infusion of autologous plasma incubated with dialy-
zer cuprophan into sheep leads to leukopenia, hy-
poxia, and cardiopulmonary disfunction [2]. Be-
cause these events are concurrent with the neutro-
penia, it has been suggested that the pulmonary
abnormalities reflect component-mediated pulmo-
nary leukostasis. This hypothesis requires that hy-
poxia occur only in patients dialyzed with mem-
branes that cause leukopenia. It does not explain
the progression of hypoxia during dialysis despite
the release of entrapped pulmonary leukocytes.
We have dialyzed four patients a total of 12 times
with artificial kidneys made of cuprophan, regener-
ated cellulose, cellulose acetate, or polyacrilonitrile.
The first three dialyzers represent variations in the
manufacturing process of cellulose that lead to
differences in dialysance properties. Polyacriloni-
true is an entirely different membrane that is used
for its ultrafiltration characteristics. As expected
with the cuprophan and regenerated cellulose
kidneys, there was profound leukopenia followed
by a rebound leukocytosis. The fall in leukocyte
count in patients dialyzed against a cellulose
acetate membrane, however, was less dramatic,
and the change with polyacrilonitrile was minimal.
This suggests less complement activation and leu-
kocyte aggregation with the latter two membranes.
In spite of these differences, hypoxia occurred in
every patient during dialysis independent of the
membrane used and progressed in severity even as
the leukocyte count returned to or exceeded pre-
dialysis values. These data suggest that leukopenia
and hypoxia may be concurrent but unrelated phe-
nomena. In a study examining complement activa-
tion and leukopenia with cuprophan, poly-
carbonate, and polyacrilonitrile membranes, Al-jama et al [9] noted that these events were not
necessarily related and could occur independently.
Moreover, a study using sequential ultrafiltration
and dialysis with similar membranes has dissociated
these phenomena [15]. Thus, the suggested se-
quence of complement activation-leukopenia-hy-
poxia may not be valid. An alternate explanation is
that the hypoxia is secondary to a depression of
ventilation due to a loss of carbon dioxide across
the kidney into dialysate [10]. This hypothesis pre-
dicts our findings that hypoxia will progress
throughout dialysis and be unrelated to leukopenia
or the membrane used.
An additional cause of hypoxia may be a progres-
sive improvement in acidosis during hemodialysis.
As acidosis is a respiratory stimulant, reversal of
acidosis would decrease minute ventilation and sub-
sequently arterial oxygen tension. The anticipated
accumulation of carbon dioxide would traverse the
membrane into the dialysate [16] or be utilized dur-
ing acetate metabolism [11]. This sequence of
events is supported by our findings of a progressive
normalization of pH without a change in Pco2 dur-
ing hemodialysis with all kidneys. The decrease in
Po2 at 20 mm with the polyacrilonitrile kidney was
minimal and not significant, suggesting that the
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early hypoxia may in fact be related to leukopenia.
Probably both factors are instrumental in causing
hypoxia at different times during hemodialysis.
A mild thrombocytopenia occurred during dial-
ysis with the cuprophan and regenerated cellulose
membranes in a pattern similar to the leukopenia
and has previously been observed in patients under-
going hemodialysis [12]. This observation is not sur-
prising in view of the finding that the cuprophan
membrane is able to degranulate and release a plate-
let-activating factor from basophils [13]. This factor
is not released during exposure to polyacrilonitrile.
Continuous exposure of plasma to the cuprophan
and regenerated cellulose membranes will activate
complement proteins and may potentially deplete
them. A slight depression of titers of C3 has been
observed early in dialysis. Myers and Klajman [14]
observed depressed levels of C3 in 9 of 13 chronic
hemodialysis patients and suggested that this may
predispose them to bacterial infection. We used he-
molytic titers of complement components as a func-
tional measure of complement activity. Functional
titers of whole complement, C3, C4, and CS were
not diminished by 4 hours of hemodialysis. Thus,
hemodialysis does not deplete complement com-
ponents, making complement abnormalities an un-
likely explanation for the predisposition of dialysis
patients to bacterial infections.
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